Search bioRxiv⌕ Search

Biology subjects

Kumawat, A. K.

Publications and source records attributed to Kumawat, A. K..

2 recordsLinked to original sources

Patients with peripheral artery disease demonstrate altered expression of soluble and membrane-bound immune checkpoints by peripheral blood immune cells

Cardiovascular events seem to occur more frequently after treatment with immune checkpoint inhibitors. This suggests a possible role of immune checkpoints in accelerating atherosclerosis formation. We therefore aimed to assess the expression of soluble and membrane-bound immune checkpoints in patients with peripheral artery disease (PAD). We assessed the levels of 14 soluble immune checkpoints in fasting blood plasma of PAD patients (intermittent claudication, n= 37) and healthy controls (HCs, n=39) by Multiplex protein assay. We measured the levels of T-cell immunoglobulin and mucin domain 3 (TIM-3), programmed cell death 1 ligand 1 and 2 (PD-L1/2), B-and T-lymphocyte attenuator (BTLA), programmed cell death 1 (PD-1), glucocorticoid-induced TNRF-related protein (GITR), herpesvirus entry mediator (HVEM), cytotoxic T-lymphocyte associated protein 4 (CTLA-4), indoleamine 2,3-dioxygenase (IDO), CD28, CD27, CD80, CD137 and lymphocyte-activation gene 3 (LAG-3). The surface expression of CD28, PD-L2, PD-1, GITR, LAG-3, TIM-3 and BTLA on peripheral blood immune cells was determined by flow cytometry. Cytokine production capacity was measured by flow cytometry in TIM-3+ T cells to determine immune exhaustion. Soluble levels of PD-L2 were decreased in PAD patients, but only in females, whereas soluble levels of TIM-3 showed a trend towards increased concentration in female PAD patients. All monocyte subsets had increased frequencies of PD-L2+ cells in PAD patients. CD4+ T cells had increased frequencies of TIM-3+ cells, which showed little overlap with other immune exhaustion markers. TIM-3+ CD4+ T cells appeared to have a low capacity to produce pro-inflammatory cytokines, but a higher capacity to produce IL-10 compared to TIM-3-CD4+ T cells. We found that PAD patients show differences in expression of both membrane-bound and soluble immune checkpoints. Some of these differences might be caused by prolonged immune activation, although immune exhaustion markers did not always overlap.

immunology↗

Effects of ageing and frailty on circulating monocyte and dendritic cell subsets

Ageing is associated with dysregulated immune responses, resulting in impaired resilience against infections and a low-grade inflammation known as inflammageing. Frailty is a measurable condition in older adults characterized by decreased health and physical impairment. Dendritic cells (DCs) and monocytes play a crucial role in initiating and steering immune responses. To assess whether their frequencies and phenotypes in the blood are affected by ageing or frailty, we performed a flow cytometry study (14 markers) on monocyte and DC subsets in an immune ageing cohort (SENEX). Participants were divided into three groups (n=15 each): healthy young controls (HYC, median age 29 years), healthy older controls (HOC, 73 years) and Frail older controls (76 years). Frailty status was based on Tilburg Frailty Index scores. Among HLA-DR+/CD19-cells, monocyte subsets (classical, intermediate, non-classical) were identified by CD14 and CD16 expression, and DC subsets (conventional (c)DC1, cDC2, plasmacytoid (p)DC) by CD11c, CD1c, CD141 and CD303 expression. Using unsupervised and conventional gating strategies, we observed a substantially lower proportion of pDCs in the HOC compared to the HYC. Additionally, we observed higher expression of activation markers on classical and intermediate monocytes and on cDC2 in HOC compared to HYC. Comparing the Frail to the age-matched HOC group, we observed only one important difference: a higher expression of CD40 on classical and non-classical monocytes in Frail individuals. In this cross-sectional study, we document a substantial effect of ageing on monocytes and DCs. The reduction of pDCs in older people may underly their impaired ability to counter viral infections, whereas the enhanced expression of activation markers could indicate a state of inflammageing. Future studies could elucidate the functional consequences of CD40 upregulation with frailty.

immunology↗